TELMA LNB 25 (Cilnidipine (10mg) + Metoprolol Succinate (25mg) + Telmisartan (40mg))

Telma-LNB 25 is a combination medication specifically formulated to manage hypertension, or high blood pressure, particularly in cases where a single drug has proven insufficient. By effectively lowering elevated blood pressure, it plays a significant role in decreasing the risks associated with severe cardiovascular events such as heart attacks and strokes. This medication is versatile in its administration; it can be taken at any point during the day alongside food, although it is advisable to maintain a consistent daily schedule for optimal results. Adherence to the prescribed regimen is crucial, as discontinuing the medication prematurely could lead to a deterioration of health, given that high blood pressure often presents with no overt symptoms. In conjunction with the medication, adopting a lifestyle that includes regular physical activity, weight management, and a balanced diet is beneficial for controlling blood pressure levels. Patients may experience side effects, such as nausea, alterations in taste, throat infections, back pain, and swelling in the ankles. To alleviate ankle swelling, elevating the legs while seated can be helpful. It is important to limit dietary intake of potassium-rich foods and supplements during treatment. Regular monitoring of blood pressure, kidney function, blood glucose, and electrolyte levels is often required during the course of treatment. Before initiating therapy with this medication, it is essential to inform your healthcare provider of any pre-existing liver or kidney conditions. Pregnant and breastfeeding individuals should seek professional guidance before commencing treatment with Telma-LNB 25.